• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含双膦酸盐和儿茶酚的化合物对细菌和人锌金属蛋白酶的抑制作用。

Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.

机构信息

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.

Department of Pharmacy, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.

出版信息

J Enzyme Inhib Med Chem. 2021 Dec;36(1):819-830. doi: 10.1080/14756366.2021.1901088.

DOI:10.1080/14756366.2021.1901088
PMID:33757387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7993378/
Abstract

Compounds containg catechol or bisphosphonate were tested as inhibitors of the zinc metalloproteases, thermolysin (TLN), pseudolysin (PLN) and aureolysin (ALN) which are bacterial virulence factors, and the human matrix metalloproteases MMP-9 and -14. Inhibition of virulence is a putative strategy in the development of antibacterial drugs, but the inhibitors should not interfere with human enzymes. Docking indicated that the inhibitors bound MMP-9 and MMP-14 with the phenyl, biphenyl, chlorophenyl, nitrophenyl or methoxyphenyl ringsystem in the S'-subpocket, while these ringsystems entered the S'- or S -subpockets or a region involving amino acids in the S'- and S'-subpockets of the bacterial enzymes. An arginine conserved among the bacterial enzymes seemed to hinder entrance deeply into the S'-subpocket. Only the bisphosphonate containing compound RC2 bound stronger to PLN and TLN than to MMP-9 and MMP-14. Docking indicated that the reason was that the conserved arginine (R203 in TLN and R198 in PLN) interacts with phosphate groups of RC2.

摘要

含儿茶酚或双膦酸盐的化合物被测试为锌金属蛋白酶的抑制剂,这些酶包括细菌毒力因子热稳定丝氨酸蛋白酶(TLN)、假丝氨酸蛋白酶(PLN)和金葡菌蛋白酶(ALN),以及人类基质金属蛋白酶 MMP-9 和 MMP-14。抑制毒力是开发抗菌药物的一种推测策略,但抑制剂不应干扰人类酶。对接表明,抑制剂与 MMP-9 和 MMP-14 结合,苯基、联苯基、氯苯基、硝基苯基或甲氧基苯基环系统位于 S'-亚口袋中,而这些环系统进入 S'-或 S-亚口袋或涉及细菌酶的 S'-和 S'-亚口袋中的氨基酸的区域。细菌酶中保守的精氨酸似乎阻碍了其深入进入 S'-亚口袋。只有含双膦酸盐的 RC2 化合物与 PLN 和 TLN 的结合比与 MMP-9 和 MMP-14 的结合更强。对接表明,原因是保守的精氨酸(TLN 中的 R203 和 PLN 中的 R198)与 RC2 的磷酸基团相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/9b59a1803d2b/IENZ_A_1901088_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/e584e21c9086/IENZ_A_1901088_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/6b2fcee76f34/IENZ_A_1901088_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/758ce45d1abf/IENZ_A_1901088_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/0ff229634ce0/IENZ_A_1901088_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/9d389041f2db/IENZ_A_1901088_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/9b59a1803d2b/IENZ_A_1901088_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/e584e21c9086/IENZ_A_1901088_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/6b2fcee76f34/IENZ_A_1901088_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/758ce45d1abf/IENZ_A_1901088_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/0ff229634ce0/IENZ_A_1901088_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/9d389041f2db/IENZ_A_1901088_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b5/7993378/9b59a1803d2b/IENZ_A_1901088_F0005_C.jpg

相似文献

1
Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.含双膦酸盐和儿茶酚的化合物对细菌和人锌金属蛋白酶的抑制作用。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):819-830. doi: 10.1080/14756366.2021.1901088.
2
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.加兰他敏和一种氮杂糖基羟肟酸化合物对人基质金属蛋白酶和细菌金属蛋白酶的选择性。
PLoS One. 2018 Aug 3;13(8):e0200237. doi: 10.1371/journal.pone.0200237. eCollection 2018.
3
Inhibition of pseudolysin and thermolysin by hydroxamate-based MMP inhibitors.羟肟酸基质金属蛋白酶抑制剂对假溶菌素和热稳定素的抑制作用。
Eur J Med Chem. 2015 Jan 7;89:340-8. doi: 10.1016/j.ejmech.2014.10.009. Epub 2014 Oct 18.
4
Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases.锌螯合物作为人源和细菌锌金属蛋白酶抑制剂。
Molecules. 2021 Dec 22;27(1):56. doi: 10.3390/molecules27010056.
5
Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.异羟肟酸酯衍生物作为锌金属蛋白酶抑制剂的合成、实验评估及分子模拟
Eur J Med Chem. 2016 Jan 27;108:141-153. doi: 10.1016/j.ejmech.2015.11.019. Epub 2015 Nov 28.
6
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.具有额外抗氧化活性的基于儿茶酚的基质金属蛋白酶抑制剂。
J Enzyme Inhib Med Chem. 2016;31(sup4):25-37. doi: 10.1080/14756366.2016.1217853. Epub 2016 Aug 24.
7
Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.4,4'-联苯磺酰胺作为选择性非锌结合基质金属蛋白酶抑制剂的动力学特征
J Enzyme Inhib Med Chem. 2015 Dec;30(6):947-54. doi: 10.3109/14756366.2014.1000889. Epub 2015 Feb 19.
8
Specific interactions between zinc metalloproteinase and its inhibitors: Ab initio fragment molecular orbital calculations.锌金属蛋白酶与其抑制剂之间的特异性相互作用:从头算片段分子轨道计算
J Mol Graph Model. 2017 Aug;75:277-286. doi: 10.1016/j.jmgm.2017.05.013. Epub 2017 Jun 8.
9
Proposal of selective inhibitor for bacterial zinc metalloprotease: Molecular mechanics and ab initio molecular orbital calculations.细菌锌金属蛋白酶选择性抑制剂的提议:分子力学和从头算分子轨道计算
J Mol Graph Model. 2022 Jan;110:108047. doi: 10.1016/j.jmgm.2021.108047. Epub 2021 Oct 11.
10
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.通过酶抑制动力学研究、蛋白质序列分析和同源性建模揭示的子宫内膜酶/基质溶素-2活性位点的中间S1'口袋。
J Biol Chem. 2003 Dec 19;278(51):51646-53. doi: 10.1074/jbc.M310109200. Epub 2003 Oct 7.

引用本文的文献

1
Identification of novel -benzyloxy-amino acid hydroxamates as inhibitors of the virulence factor LasB from .鉴定新型苄氧基氨基酸异羟肟酸酯作为铜绿假单胞菌毒力因子LasB的抑制剂。 (注:原文中“from.”表述不完整,推测补充为“from Pseudomonas aeruginosa”进行翻译,具体需结合完整原文确定)
RSC Med Chem. 2025 Aug 13. doi: 10.1039/d5md00393h.
2
Interactions of substrates and phosphinyl containing inhibitors with bacterial and human zinc proteases.底物及含磷酰基抑制剂与细菌和人类锌蛋白酶的相互作用。
PLoS One. 2025 Aug 1;20(8):e0329362. doi: 10.1371/journal.pone.0329362. eCollection 2025.
3
The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery.

本文引用的文献

1
Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer.稳定前基质金属蛋白酶 9·丝氨酸糖蛋白异源二聚体的分子相互作用。
Int J Mol Sci. 2020 Jun 12;21(12):4205. doi: 10.3390/ijms21124205.
2
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.加兰他敏和一种氮杂糖基羟肟酸化合物对人基质金属蛋白酶和细菌金属蛋白酶的选择性。
PLoS One. 2018 Aug 3;13(8):e0200237. doi: 10.1371/journal.pone.0200237. eCollection 2018.
3
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database.
严重急性呼吸综合征冠状病毒2型主要蛋白酶的酶原形式:药物研发的一个独特靶点。
J Biol Chem. 2025 Jan;301(1):108079. doi: 10.1016/j.jbc.2024.108079. Epub 2024 Dec 14.
4
Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives.细菌金属锌酶抑制剂:最新进展与未来展望。
Molecules. 2023 May 27;28(11):4378. doi: 10.3390/molecules28114378.
5
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14.利用遗传密码扩展来修饰 N-TIMP2 对 MMP-2、MMP-9 和 MMP-14 的特异性。
Sci Rep. 2023 Mar 30;13(1):5186. doi: 10.1038/s41598-023-32019-3.
6
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14.利用遗传密码扩展来改变N-组织金属蛋白酶抑制剂2对基质金属蛋白酶-2、基质金属蛋白酶-9和基质金属蛋白酶-14的特异性。
Res Sq. 2023 Jan 16:rs.3.rs-2446107. doi: 10.21203/rs.3.rs-2446107/v1.
7
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II.D-多巴是谷氨酸羧肽酶II的一种强效、口服生物可利用的变构抑制剂。
Pharmaceutics. 2022 Sep 23;14(10):2018. doi: 10.3390/pharmaceutics14102018.
8
Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases.锌螯合物作为人源和细菌锌金属蛋白酶抑制剂。
Molecules. 2021 Dec 22;27(1):56. doi: 10.3390/molecules27010056.
9
Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms.多功能合成抗菌肽及其抗菌、抗真菌和抗病毒机制。
Int J Mol Sci. 2022 Jan 4;23(1):545. doi: 10.3390/ijms23010545.
MEROPS 数据库收录了 2017 年的蛋白水解酶、其底物和抑制剂,以及与 PANTHER 数据库中肽酶的比较。
Nucleic Acids Res. 2018 Jan 4;46(D1):D624-D632. doi: 10.1093/nar/gkx1134.
4
Biochemical and Biological Attributes of Matrix Metalloproteinases.基质金属蛋白酶的生化及生物学特性
Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22.
5
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.抗药性时代的新型抗生素:针对有害细菌的抗毒力策略。
Nat Rev Drug Discov. 2017 Jul;16(7):457-471. doi: 10.1038/nrd.2017.23. Epub 2017 Mar 24.
6
Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.宿主-病原体相互作用的药理学靶向:对抗耐药超级细菌的传统抗生素替代方案
Trends Pharmacol Sci. 2017 May;38(5):473-488. doi: 10.1016/j.tips.2017.02.003. Epub 2017 Mar 8.
7
Rational Design of Thermodynamic and Kinetic Binding Profiles by Optimizing Surface Water Networks Coating Protein-Bound Ligands.通过优化包被蛋白质结合配体的表面水网络对热力学和动力学结合曲线进行合理设计。
J Med Chem. 2016 Dec 8;59(23):10530-10548. doi: 10.1021/acs.jmedchem.6b00998. Epub 2016 Nov 30.
8
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.具有额外抗氧化活性的基于儿茶酚的基质金属蛋白酶抑制剂。
J Enzyme Inhib Med Chem. 2016;31(sup4):25-37. doi: 10.1080/14756366.2016.1217853. Epub 2016 Aug 24.
9
Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.超越抗生素:细菌感染的新治疗方法
Clin Infect Dis. 2016 Jul 1;63(1):89-95. doi: 10.1093/cid/ciw200. Epub 2016 Mar 29.
10
Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.异羟肟酸酯衍生物作为锌金属蛋白酶抑制剂的合成、实验评估及分子模拟
Eur J Med Chem. 2016 Jan 27;108:141-153. doi: 10.1016/j.ejmech.2015.11.019. Epub 2015 Nov 28.